Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
Pakistan · Delayed Price · Currency is PKR 892.00
+0.33 (0.04%)
At close: May 11, 2026
PSX:ABOT Cash Flow Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 8,307 | 7,967 | 5,234 | 261.78 | 3,004 | 5,967 |
Depreciation & Amortization | 1,931 | 1,890 | 1,780 | 1,583 | 1,440 | 1,236 |
Other Amortization | - | - | - | 0.27 | 3.29 | 18.95 |
Loss (Gain) From Sale of Assets | -31.89 | -113.38 | -31.14 | -20.26 | 94.33 | -18.92 |
Asset Writedown & Restructuring Costs | 349.57 | 349.57 | 225.04 | - | - | - |
Stock-Based Compensation | 371.37 | 323.42 | 313.32 | 378.52 | 166.49 | 124.54 |
Provision & Write-off of Bad Debts | 142.56 | 142.56 | 47.86 | -11.44 | 11.48 | -26.18 |
Other Operating Activities | -40.58 | 556.29 | 517.37 | -1,152 | 52.63 | 584.43 |
Change in Accounts Receivable | 271.34 | 19.59 | -1,381 | -361.42 | -71.87 | -254.61 |
Change in Inventory | -4,657 | -2,532 | 1,702 | -4,947 | -2,049 | -2,152 |
Change in Accounts Payable | 3,026 | 1,526 | -4,140 | 4,189 | 2,827 | 2,459 |
Change in Other Net Operating Assets | -285.21 | 639.18 | 424.97 | 46.35 | -1,687 | -112.42 |
Operating Cash Flow | 9,362 | 10,740 | 4,674 | -62.3 | 3,797 | 7,823 |
Operating Cash Flow Growth | 63.44% | 129.78% | - | - | -51.47% | -3.99% |
Capital Expenditures | -3,114 | -3,299 | -3,022 | -3,075 | -3,585 | -2,055 |
Sale of Property, Plant & Equipment | 161.64 | 280.19 | 181.55 | 139.85 | 182.08 | 87.72 |
Sale (Purchase) of Intangibles | - | - | - | - | - | -5 |
Investment in Securities | - | - | - | - | 2,000 | -2,000 |
Other Investing Activities | 611.8 | 535.1 | 472.18 | 735.63 | 918.55 | 536.51 |
Investing Cash Flow | -2,340 | -2,484 | -2,368 | -2,199 | -484.05 | -3,436 |
Long-Term Debt Repaid | - | -54.14 | -105.99 | -89.07 | -102.31 | -825.32 |
Net Debt Issued (Repaid) | -81.86 | -54.14 | -105.99 | -89.07 | -102.31 | -825.32 |
Common Dividends Paid | -969.23 | -971.56 | -1,030 | -1,374 | -1,016 | -4,398 |
Other Financing Activities | -91.9 | -75.66 | -23.61 | -30.29 | -21.99 | -33.89 |
Financing Cash Flow | -1,143 | -1,101 | -1,160 | -1,494 | -1,140 | -5,257 |
Net Cash Flow | 5,879 | 7,155 | 1,146 | -3,755 | 2,172 | -869.53 |
Free Cash Flow | 6,249 | 7,441 | 1,652 | -3,137 | 212.23 | 5,768 |
Free Cash Flow Growth | 146.69% | 350.45% | - | - | -96.32% | -14.77% |
Free Cash Flow Margin | 8.25% | 9.87% | 2.42% | -5.65% | 0.43% | 13.55% |
Free Cash Flow Per Share | 63.83 | 76.01 | 16.87 | -32.04 | 2.17 | 58.92 |
Cash Interest Paid | 82.7 | 66.46 | 11.74 | 22.18 | - | - |
Cash Income Tax Paid | 5,778 | 5,020 | 3,431 | 2,859 | 2,595 | 1,853 |
Levered Free Cash Flow | 5,798 | 7,969 | 474.06 | -2,467 | 3,796 | 5,279 |
Unlevered Free Cash Flow | 5,848 | 8,010 | 481.4 | -2,454 | 3,812 | 5,313 |
Change in Working Capital | -1,645 | -347.61 | -3,394 | -1,073 | -981.05 | -60.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.